Cloverleaf Bio develops innovative RNA therapeutics designed to transform cancer treatment. Their focus is on creating targeted solutions that aim to improve efficacy and safety for cancer patients.
Founded
2023
Total Funding
$10M+
Total Rounds
1
First Raise
Sep 8, 2026
Latest Raise
Sep 8, 2026
New funding rounds in your inbox every week 路 No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 9/8/2026 | |||
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week 路 Free